Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,717 | -15,586 | -8,402 | -10,516 | -9,103 |
| Depreciation Amortization | -717 | -9 | N/A | N/A | N/A |
| Other Working Capital | 394 | 498 | -1,354 | 1,646 | 318 |
| Other Operating Activity | 1,838 | 8,693 | 1,898 | 1,641 | 1,468 |
| Operating Cash Flow | $-12,201 | $-6,404 | $-7,858 | $-7,229 | $-7,317 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -63,453 | -14,338 | 4,928 | -4,919 | N/A |
| Investing Cash Flow | $-63,453 | $-14,338 | $4,928 | $-4,919 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 127,707 | 59,397 | 2,074 | 110 | 10,943 |
| Common Stock Repurchased | -35,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,132 | -104 | -47 | -77 | -63 |
| Financing Cash Flow | $91,574 | $59,292 | $2,027 | $33 | $10,880 |
| Exchange Rate Effect | 97 | 1 | -17 | -4 | 5 |
| Beginning Cash Position | 45,816 | 7,266 | 8,186 | 20,304 | 16,737 |
| End Cash Position | 61,834 | 45,816 | 7,266 | 8,186 | 20,304 |
| Net Cash Flow | $16,017 | $38,550 | $-920 | $-12,118 | $3,567 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,201 | -6,404 | -7,858 | -7,229 | -7,317 |
| Free Cash Flow | -12,201 | -6,404 | -7,858 | -7,229 | -7,317 |